Haagdorens, Michel http://orcid.org/0000-0003-1568-556X
Edin, Elle http://orcid.org/0000-0001-8465-1764
Fagerholm, Per http://orcid.org/0000-0002-6767-4769
Groleau, Marc http://orcid.org/0000-0001-9291-6929
Shtein, Zvi
Ulčinas, Artūras http://orcid.org/0000-0003-2022-3116
Yaari, Amit
Samanta, Ayan
Cepla, Vytautas http://orcid.org/0000-0002-1433-3274
Liszka, Aneta
Tassignon, Marie-José http://orcid.org/0000-0001-8302-8006
Simpson, Fiona http://orcid.org/0000-0003-3534-050X
Shoseyov, Oded http://orcid.org/0000-0003-3340-9921
Valiokas, Ramūnas http://orcid.org/0000-0003-4807-9136
Pintelon, Isabel http://orcid.org/0000-0003-2901-4679
Ljunggren, Monika Kozak http://orcid.org/0000-0002-6116-1524
Griffith, May http://orcid.org/0000-0003-1222-6720
Funding for this research was provided by:
Linköping University
Article History
First Online: 6 August 2021
Declarations
:
: The Declaration of Helsinki guidelines were applied and were approved by the Antwerp University Hospital Ethical Committee (EC: 14/30/319) for use of human amniotic membrane. Animal experiments in rats and Göttingen minipigs were performed in accordance with the Association for Research in Vision and Ophthalmology Statement for the Use of Animals in Ophthalmic and Vision Research and the Swedish Animal Welfare Ordinance and the Animal Welfare Act, after ethical approval was acquired from the local Linkoping ethical committee (Linköpings Djurförsöksetiska Nämnd).
: Dr. Oded Shoseyov is a founder and chief scientist at CollPlant which produces and markets tobacco-derived RHCI. Other authors have no competing interests.